CollPlant Biotechnologies (CLGN) Gross Profit (QoQ) (2018 - 2026)
CollPlant Biotechnologies (CLGN) Gross Profit (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -84.09% |
| Dec 31, 2025 | 31.25% |
| Sep 30, 2025 | 100.00% |
| Jun 30, 2025 | -375,033.05% |
| Mar 30, 2025 | 1,828.70% |
| Dec 31, 2024 | 59.70% |
| Sep 30, 2024 | 6.62% |
| Jun 30, 2024 | 35.79% |
| Mar 31, 2024 | 5.70% |
| Dec 31, 2023 | -101.70% |
| Sep 30, 2023 | -102.46% |
| Jun 30, 2023 | 8,760.19% |
| Mar 31, 2023 | 2,800.00% |
| Dec 31, 2022 | 97.42% |
| Sep 30, 2022 | -773.91% |
| Jun 30, 2022 | -34.29% |
| Mar 31, 2022 | 114.71% |
| Dec 31, 2021 | 99.99% |
| Sep 30, 2021 | -763,458.78% |
| Jun 30, 2021 | -98.08% |